Log in or Sign up for Free to view tailored content for your specialty!
Drug/Insect/Latex News
Split dosing of COVID-19 vaccines provides antibody responses
Split doses of COVID-19 vaccines were able to provide antibody responsiveness among patients with allergic reactions to previous doses, according to a letter published in Annals of Allergy, Asthma & Immunology.
Commentary: Celebrate National Penicillin Allergy Day by de-labeling your patients
After patients experience potential allergic reactions to a medicine, they can suffer several long-term adverse consequences that people do not often think about.
Log in or Sign up for Free to view tailored content for your specialty!
Guidelines describe how non-allergists can de-label penicillin allergies
The British Society for Allergy and Clinical Immunology has released guidelines for clinicians in the U.K. who are not trained in allergy or immunology to evaluate and test patients with an unsubstantiated label of penicillin allergy.
Data continue to show COVID-19 revaccination safe for patients following initial reaction
Patients who have an adverse event immediately after COVID-19 vaccination can be revaccinated if they are selected carefully and challenged in a supervised environment, according to a letter published in Allergy.
Interventions may reduce ED reutilization after amoxicillin-associated reactions
Fever, angioedema, joint involvement and gastrointestinal symptoms were among the factors that predicted ED and urgent care reutilization among children with amoxicillin-associated reactions, according to study results.
Patients with history of skin reactions to heparin tolerate IV administration
Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV administration of the medication, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Following reactions to first COVID-19 vaccine, children can safely receive second dose
Children with immediate allergic reactions to their first dose of the Pfizer-BioNTech COVID-19 vaccine safely received the second dose, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Novel ‘hub-and-spoke’ model accelerates allergy assessments before COVID-19 vaccinations
A clinical “hub-and-spoke” model expanded allergy assessments and increased the number of safe COVID-19 vaccinations in Hong Kong, according to a study presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress.
Antibiotic allergies often inaccurately documented in tertiary pediatric hospital setting
Antibiotic allergies frequently were incompletely and inconsistently documented in a tertiary pediatric hospital setting, according to a study presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress.
‘Hidden allergen’ in MMR vaccine may cause anaphylaxis in children with cow’s milk allergy
Two children with severe cow’s milk allergy developed anaphylactic reactions after receiving doses of a measles, mumps and rubella — or MMR — vaccine that included the alpha-lactoglobulin component of milk, researchers reported.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read